HOTH vs ZBH · rev $1.24B vs P/E 23, rev $4.26B
Hoth Therapeutics Inc (HOTH) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
HOTH currently screens at market cap $15.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the HOTH and ZBH stock pages for the full models.
Not investment advice.